Nanotherapeutics and Nanotheragnostics for Cancers: Properties, Pharmacokinet-ics, Biopharmaceutics, and Biosafety

• Tipo: Outra Publicação em Revista Científica Internacional
• Data: 2022

Autores

Morsink, M (Autor) Outra; Parente, L (Autor) Outra; Silva, F (Autor) Outra; Abrantes, A (Autor) Outra; Ramos, A (Autor) Outra; Primo, I (Autor) Outra; Willemen, N (Autor) Outra; Sanchez Lopez, E (Autor) Outra; Severino, P (Autor) Outra; Souto, EB (Autor) FFUP

Revista

Título: Current Pharmaceutical Design

Vol. 28

Páginas: 104-115

ISSN: 1381-6128

Editora: Bentham Science

Indexação

ISI Web of Knowledge - 0 Citações

Scopus - 1 Citação

Classificação Científica

CORDIS: Ciências da Saúde

Outras Informações

ID Authenticus: P-00V-XQ9

DOI: 10.2174/1381612827666210804102645

Abstract (EN): With the increasing worldwide rate of chronic diseases, such as cancer, the development of novel techniques to improve the efficacy of therapeutic agents is highly demanded. Nanoparticles are especially well suited to encapsulate drugs and other therapeutic agents, bringing additional advantages, such as less frequent dosage requirements, reduced side effects due to specific targeting, and therefore increased patient compliance. However, with the increasing use of nanoparticles and their recent launch on the pharmaceutical market, it is important to achieve high-quality control of these advanced systems. In this review, we discuss the properties of different nanoparticles, the pharmacokinetics, the biosafety issues of concern, and conclude with novel nanotherapeutics and nanotheragnostics for cancer drug delivery.

Idioma: Inglês

Tipo (Avaliação Docente): Científica

Nº de páginas: 12